As geopolitical concerns create hurdles for cross-border collaboration in biotechnology and life sciences, maintaining visibility into evolving national security and trade requirements is critical for effective global partnering. Wilson Sonsini’s National Security and Trade team invites you to join a webinar exploring recent national security and trade law developments affecting life sciences companies, including how companies are navigating the resulting challenges.

The discussion will be moderated by Life Sciences partner Farah Gerdes, and features Seth Cowell and Anne Seymour of the National Security and Trade team, who will discuss key developments shaping the landscape, including:

• The BIOSECURE Act, new DOJ data export rules, potential pharmaceutical tariffs, and expanding prohibited-party lists.
• How life sciences companies are addressing related national security concerns – both through traditional toolsets and in response to these emerging developments – in their cross-border investment and commercial transactions.